Patients with hard-to-treat autoimmune hepatitis (AIH) or primary biliary cholangitis (PBC) are defined a posteriori as those who do not show a sufficient response or are intolerant to pharmacological treatments, thus not achieving biochemical surrogate endpoints that are associated with long-term liver-related-event-free survival. The absence of a recently harmonized definition of ‘complete biochemical response within 6 months (CBR≤6M)’, which is defined as the normalization of serum transaminase and IgG levels below the upper limit of normal at ≤6 months after treatment initiation, is regarded as hard-to-treat AIH. The implementation of CBR≤6M, in turn, has been facilitating clinical trials, e.g., between azathioprine and mycophenolate mofetil, to reconsider appropriate first-line steroid sparing agents, leading to a reduction in the number of hard-to-treat AIH cases. Regarding PBC, one of the disseminated definitions of hard-to-treat patients is the absence of POISE criteria, which are evaluated at 12 months with serum alkaline phosphatase and bilirubin levels, after the introduction of ursodeoxycholic acid. Hard-to-treat PBC not meeting the POISE criteria has very recently been the target population for the U.S. FDA-approved second-line drugs, elafibranor and seladelpar. In future pharmacological treatment of AIH and PBC, the primary objective for AIH is likely to focus on lowering the number of hard-to-treat patients with personalized steroid sparing treatment regimens. A challenging goal in PBC treatment is the further optimization of treatment surrogate endpoints, even to the stricter alkaline phosphatase normalization, with which an indication of second- or later-line drugs might be expanded, but could ultimately lengthen patients’ long-term survival.
Citations
Citations to this article as recorded by
Clinical Characteristics and Long‐Term Prognosis of Primary Biliary Cholangitis in Japan: Results of the 2nd‐Generation Nationwide Survey Yuki Kugiyama, Masanori Abe, Tadashi Namisaki, Hitoshi Yoshiji, Kazumichi Abe, Hiromasa Ohira, Ryosaku Shirahashi, Keiji Yokoyama, Atsushi Fukunaga, Kazuhito Kawata, Masahiro Umemura, Akira Honda, Tadashi Ikegami, Shiho Miyase, Toshiaki Nakano, Atsumasa K Hepatology Research.2026; 56(1): 50. CrossRef
Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications Mina Komuta, Kenichi Harada Hepatology Research.2026; 56(2): 139. CrossRef
Viral manipulation of host cell glutamine metabolism and glutamine rewiring in hepatic diseases: Editorial on “Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalentl Mehrangiz Dezhbord, Kyun-Hwan Kim Clinical and Molecular Hepatology.2026; 32(1): 385. CrossRef
PBC-AIH Overlap Syndrome: Diagnostic Challenges, Clinical Recognition of the
“Grey Zone” and Treatment Updates 红静 王 Advances in Clinical Medicine.2026; 16(04): 2281. CrossRef
Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review Tatsuo Kanda, Reina Sasaki-Tanaka, Naruhiro Kimura, Hiroyuki Abe, Tomoaki Yoshida, Kazunao Hayashi, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya, Kenya Kamimura, Shuji Terai International Journal of Molecular Sciences.2025; 26(5): 1883. CrossRef
The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine Xinyi Men, Yansheng Liu, Han Zhao, Bingrui Xie, Changcun Guo, Patrick S. C. Leung, Suraj Timilsina, M. Eric Gershwin, Yulong Shang, Ying Han Clinical Reviews in Allergy & Immunology.2025;[Epub] CrossRef
Autoimmune Hepatitis: Histopathological Spectrum and Diagnostic Implications Mina Komuta, Kenichi Harada Kanzo.2025; 66(11): 473. CrossRef
Die primär sklerosierende Cholangitis als cholestatische Lebererkrankung und Modellerkrankung einer gestörten Darm-Leber-Achse Philipp Dignus, Jörg Albert, Jan G. Hengstler, Christian Trautwein Die Gastroenterologie.2026; 21(1): 14. CrossRef
Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial” Woo Hyun Paik, Do Hyun Park Clinical and Molecular Hepatology.2025; 31(2): e158. CrossRef
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment Atsumasa Komori, Yuki Kugiyama Clinical and Molecular Hepatology.2025; 31(1): 90. CrossRef
Histopathology of Autoimmune Hepatitis: An Update Despoina Myoteri, Stratigoula Sakellariou, Dina G. Tiniakos Advances in Anatomic Pathology.2025; 32(6): 414. CrossRef
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis George Dalekos, Nikolaos Gatselis, Joost P. Drenth, Michael Heneghan, Marianne Jørgensen, Ansgar W. Lohse, Maria Londoño, Luigi Muratori, Maria Papp, Marianne Samyn, Dina Tiniakos, Ana Lleo Journal of Hepatology.2025; 83(2): 453. CrossRef
Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms Rolf Teschke, Axel Eickhoff, Gaby Danan Diagnostics.2025; 15(13): 1588. CrossRef
Reply to: “Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis” Haeryoung Kim, Sook-Hyang Jeong Clinical and Molecular Hepatology.2024; 30(2): 291. CrossRef
A Case of Autoimmune Hepatitis Initially Manifesting as Hepatic Encephalopathy Shengmin Yang, Ning Zhang, Xiang Li, Yunlong Li, Liangrui Zhou, Yuchen Wei, Kanghao Zhou, Hui Pan, Lin Kang Cureus.2024;[Epub] CrossRef
Reply to correspondence on “Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity” Atsumasa Komori Clinical and Molecular Hepatology.2024; 30(4): 1035. CrossRef
Autoimmune hepatitis (AIH) is an immunoinflammatory chronic liver disease with dynamic and rather heterogeneous disease manifestations. A trend of increasing prevalence of AIH has been observed worldwide, along with a relative increase in the percentage of male patients. AIH is characterized and diagnosed based on serum biochemistry and liver histology: elevated aminotransferases and serum immunoglobulin G (IgG), the presence of serum anti-nuclear antibody or anti-smooth muscle antibody, and interface lympho-plasmacytic hepatitis. Clinical manifestations differ among disease subtypes with distinct time-frames, i.e., AIH with a chronic insidious onset, and acute-onset AIH (the diagnosis of which is often challenging due to the lack of typical serum findings). The absence of disease-specific biomarkers or histological findings may expand the disease phenotype into drug-induced AIH-like liver injury. Corticosteroids and azathioprine are recommended first-line treatments for AIH. The complete normalization of aminotransferases and serum IgG is an essential treatment response to ensure long-term overall survival. An incomplete response or intolerance to these drugs is considered an indication for second-line treatment, especially with mycophenolate mofetil. Life-long maintenance treatment is required for the majority of patients, but the few who achieve prolonged and stringent biochemical remission with lower alanine aminotransferase and IgG within the normal range may be able to discontinue the medications. In the future, the quality of life of AIH patients should be managed by personalized medicine, including the appropriate selection and dosing of first-line therapy and perhaps alternating with potential therapeutics, and the prediction of the success of treatment withdrawal.
Citations
Citations to this article as recorded by
Noonan syndrome and autoimmune hepatitis: patient report and literature review Aurora Pescini, Nina Tyutyusheva, Giuseppe Indolfi, Chiara Rubino, Federica Sodini, Diego Peroni, Silvano Bertelloni Journal of Pediatric Endocrinology and Metabolism.2026; 39(1): 81. CrossRef
Expanded but dysfunctional regulatory T cells in treatment-naïve autoimmune hepatitis Mi Hyun Kwon, Eun Ji Jang, Kwon Yong Tak, Hee Sun Cho, Ji Won Han, Eui Soo Han, Younghoon Kim, Hyun Lee, Jeong Won Jang, Sung Hak Lee, Pil Soo Sung Hepatology International.2026; 20(1): 163. CrossRef
Association between thyroid diseases and autoimmune hepatitis: A bidirectional Mendelian randomization study Yunda Zhang, Haiqun Xia, Shengfei Yang, Mengling Wei, Ming Liu, Dachao Mo, Dongwei Li Medicine.2026; 105(4): e47312. CrossRef
Anti-Inflammatory Effects of Goat Whey Protein in Concanavalin-A Induced Hepatitis Natalia Solovjova, Marija Milovanovic, Aleksandar Arsenijevic, Vladislav Volarevic, Ivica Petrovic, Mirjana Grujcic, Jelena Nedeljkovic, Dragana Arsenijevic, Vesna Rosic, Nemanja Jovicic, Jelena Milovanovic Nutrients.2026; 18(5): 766. CrossRef
Differentiating Autoimmune Hepatitis From Sulfasalazine Toxicity: The Value of Clinicopathologic Correlation Adam Zoubi, Bibek Bakhati Cureus.2026;[Epub] CrossRef
Liver transplant and autoimmune liver diseases: An up-to-date review João P C Freire, Caio F Lopes, Pedro H M Lima, Lucas D Feliciano, Fabrício F de Melo World Journal of Gastrointestinal Surgery.2026;[Epub] CrossRef
Periodontitis and Chronic Liver Disease: Mechanistic Insights Focusing on Porphyromonas gingivalis—A Narrative Review Yue Ying, Yuwei Nie, Jiahui Zhao, Qin Dong, Meixian Chen, Aijia Jiang, Nan Liu, Tong Xu, Junchao Liu, Yaping Pan, Li Lin, Dongmei Zhang Microorganisms.2026; 14(4): 736. CrossRef
Dracocephalum tanguticum Maxim Polysaccharide Ameliorate Autoimmune Hepatitis via Regulating TNF and IL‐17 Signaling Pathways Min Guo, Saixue Wei, Biaobiao Cheng, Xiaodong Li Food Science & Nutrition.2026;[Epub] CrossRef
From Immunization to Autoimmunity: A Deep Dive Into Post‐COVID‐19 Vaccine Reactions—A Narrative Review Mohammad Javad Yousefi‐Hashemabad, Saeed Hashemi, Kiarash Saleki, Seyed Mohamad Kazem Nourbakhsh, Andia Saleki, Zahra Hassanzadeh, Abbas Azadmehr Health Science Reports.2026;[Epub] CrossRef
The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiome Yifan Zhang, Hongkun Li, Fei Yu, Mengmeng Gao, Yang Wang, Siyu Xin, Jiating Yang, Zhiwei Wang, Lujie Xiang, Qingjing Ru, Na Jiang Chinese Medicine.2026;[Epub] CrossRef
PBC-AIH Overlap Syndrome: Diagnostic Challenges, Clinical Recognition of the
“Grey Zone” and Treatment Updates 红静 王 Advances in Clinical Medicine.2026; 16(04): 2281. CrossRef
The SLE Conundrum: A Comprehensive Analysis of Pathogenesis, Recent Developments, and the Future of Therapeutic Interventions
Uddeshya Sharma Critical Reviews in Immunology.2025; 45(1): 41. CrossRef
Unveiling the interplay between hepatocyte SATB1 and innate immunity in autoimmune hepatitis Shuhui Wang, Zheng Huang, Shangshu Nie, Yu Chen, Yu Lei, Wei Tu, Min Luo, Zhen-gang Zhang, De-an Tian, Jin Gong, Mei Liu International Immunopharmacology.2025; 144: 113712. CrossRef
Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis Yan Wang, Yu Su, Tiantian Guo, Mengyu Zhao, Liwei Liu, Wei Chen, Xinyan Zhao Expert Opinion on Drug Metabolism & Toxicology.2025; 21(3): 315. CrossRef
A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases Lynn Khoon, Ron Piran International Journal of Molecular Sciences.2025; 26(1): 410. CrossRef
Hsa_circ_0109623 regulates the progression of autoimmune liver disease through Hsa_miR_146b-3p/Sortilin 1–mediated activation of CD4+ T cells Xinliang Lv, Li Zhu, Shijie Feng, Siyu Yang, Guohua Li, Jinqin Zhan, Yuchun Tan, Yuquan Liu, Jinliang Zhang, Yujin Wang, Yucheng Cheng, Ping Fu, Yushan Xu, Chenhong Zheng Hepatology Communications.2025;[Epub] CrossRef
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment Atsumasa Komori, Yuki Kugiyama Clinical and Molecular Hepatology.2025; 31(1): 90. CrossRef
An atypical presentation of autoimmune hepatitis with delayed menarche in a Nigerian adolescent: a case report Promise Udoka Asogwa, Bruno Basil, Winifred Njideka Adiri, Nelson Ugwu, Gideon Ekene Anigbo, Evaristus Offia, Casmir Orjioke Journal of Medical Case Reports.2025;[Epub] CrossRef
Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study Sung Won Chung, Ye-Jee Kim, Jihye Lim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sehee Kim, Won-Mook Choi American Journal of Gastroenterology.2025; 120(10): 2302. CrossRef
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations Chaojie Yu, Wenrui Wang, Qian Zhang, Zhenjing Jin Frontiers in Immunology.2025;[Epub] CrossRef
Allyl methyl disulfide attenuates liver injury induced by concanavalin A by suppressing M1 polarization of macrophages and NLRP3 inflammasome activation Mingjie Song, Xuan Gao, Dong Cheng, Ruilong Li, Xuemeng Wang, Tao Zeng, Cuili Zhang International Immunopharmacology.2025; 149: 114149. CrossRef
Disulfiram alleviates immune-mediated liver injury by inhibiting pyroptosis in hepatocytes through the NF-κB pathway Wanyuan Xiong, Junfeng Li, Xiaorong Mao, Zibing Qian, Aiping Tian, Xuebin Peng, Zhongxia Yang, Haixia Li, Ziyi Li European Journal of Pharmacology.2025; 992: 177352. CrossRef
IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury Liwu Zeng, Yaxin Wang, Yongzhou Huang, Wenchang Yang, Pei Zhou, Yaqi Wan, Kaixiong Tao, Ruidong Li Cell Communication and Signaling.2025;[Epub] CrossRef
Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database Bu-kun Zhu, Si-ying Chen, Xiang Li, Shu-yun Huang, Zhan-yang Luo, Wei Zhang Scientific Reports.2025;[Epub] CrossRef
Cholestatic Phenotype in Autoimmune Hepatitis: A Rare Presentation Vutukuri Bhargava Sai Srinath, Fatima Shahid, Muhammad Nabeel Saddique, Hassan Mumtaz, Javed Iqbal Digestive Diseases and Sciences.2025; 70(5): 1733. CrossRef
Ethyl acetate extract from Herpetospermun cardigerum wall. Ameliorated concanavalin A-induced autoimmune hepatitis in mice by reprofiling gut microenvironment to modulate IDO1/KYN and PI3K/AKT/NF-κB pathways Yu Xiao, Tianfeng Luo, Changsong Duan, Xinhui Wang, Yixi Yang, Rui Li, Jinpeng Deng, Qi Zhao Journal of Ethnopharmacology.2025; 345: 119578. CrossRef
Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference Valentina Peta, Yuliya Sandler, Olivier Deckmyn, Oksana Duroselle, Elena Vinnitskaya, Sergey Khomeriki, Karina Noskova, Thierry Poynard World Journal of Hepatology.2025;[Epub] CrossRef
Sensitivity and stability of Balb/c, C57BL/6J, and ICR mice to the acute liver injury induced by concanavalin A Mingjie Song, Xuan Gao, Ruirui Kou, Na Liu, Xiaomin Ma, Tao Zeng, Cuili Zhang Toxicology Research.2025;[Epub] CrossRef
Extracellular Inosine Induces Anergy in B Cells to Alleviate Autoimmune Hepatitis Nana Cui, Qiwei Qian, Yujie Zhou, Heng Zhang, Huayang Zhang, Binghong Wang, Yikang Li, Qixia Wang, Min Lian, Zhengrui You, Xiong Ma Cellular and Molecular Gastroenterology and Hepatology.2025; 19(10): 101539. CrossRef
Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms Rolf Teschke, Axel Eickhoff, Gaby Danan Diagnostics.2025; 15(13): 1588. CrossRef
Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis Jihye Lim, Ye-Jee Kim, Sehee Kim, Ju Hyun Shim, Ashraf Elbahrawy PLOS One.2025; 20(7): e0325066. CrossRef
Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature review Marta Giacomelli, Simone Carotti, Federico Vozella, Federica Pagliei, Chiara Taffon, Andrea Baiocchini, Francesco Luigi Gambaro, Antonio Picardi, Umberto Vespasiani-Gentilucci, Giovanni Galati World Journal of Hepatology.2025;[Epub] CrossRef
MiR-122-5p modulates ferroptosis via SLC7A11: A potential therapeutic target in autoimmune hepatitis Yuhong Suo, Yu Wang, Yu Su, Qianyi Wang, Jidong Jia, Xinyan Zhao Journal of Translational Autoimmunity.2025; 11: 100303. CrossRef
Difficult to treat and refractory autoimmune hepatitis: Recent advances in pharmacological management Sayan Malakar, Umair Shamsul Hoda, Suprabhat Giri, Arghya Samanta, Akash Roy, Rajat Gupta, S Rakesh Kumar, Mayank Agarwal, Anubhav Pawar, Sumit Rungta, Uday C Ghoshal World Journal of Hepatology.2025;[Epub] CrossRef
Long-Term Prednisone Use Increases Hepatocellular Carcinoma Risk in Autoimmune Hepatitis Cirrhosis: A Retrospective Cohort Study Jessica Liu, Rami Hemadeh, Abdelrahman M. Attia, Pojsakorn Danpanichkul, Hasmik Adetyan, Naomy Kim, Tamar Yalda, Ju Dong Yang, Manaf Alsudaney, Walid Ayoub Gastro Hep Advances.2025; 4(10): 100784. CrossRef
Multi-omics profiling uncovers paradoxical Epstein-Barr virus involvement in autoimmune liver disease pathogenesis Linyi Zheng, Yuqiang Li, Cenap Güngör, Heming Ge AMB Express.2025;[Epub] CrossRef
Mendelian randomization of autoimmune hepatitis and cardiovascular diseases Feng Tang, Tian Jun Zhao, Pei Wen Dong, Kai Di Sun, Xiao Bin Sun, Qiong Wang American Heart Journal Plus: Cardiology Research and Practice.2025; 59: 100627. CrossRef
Liver and spleen volumes in children with autoimmune hepatitis: association with laboratory parameters and fibrosis stage. A single-center, ambispective, cohort, non-randomized study Daria V. Parakhina, Alexander S. Potapov, Matvey A. Zimin, Goar B. Movsisyan, Alexey I. Firumyants, Anatoly V. Anikin Pediatrics. Consilium Medicum.2025; (3): 274. CrossRef
Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies Giorgio Cazzaniga, Francesca Bolis, Chiara Caime, Rocco Piazza, Laura Žigutytė, Jakob Nikolas Kather, Fabio Pagni, Pietro Invernizzi, Marco Carbone, Alessio Gerussi Liver International.2025;[Epub] CrossRef
Evaluation of the effectiveness of ChatGPT in supporting the management of autoimmune hepatitis effectiveness of ChatGPT in autoimmune hepatitis Muhammed Mustafa İnce, Ersan Özaslan BMC Gastroenterology.2025;[Epub] CrossRef
Beyond biochemical remission: roadmap for integrating health-related quality of life into autoimmune hepatitis management and research DuJiang Yang, GuoYou Wang Hepatology International.2025;[Epub] CrossRef
Wilson’s Disease with Autoimmune Hepatitis Manifestation in a Pediatric Patient: A Case Report and Literature Review Nicoleta Gimiga, Gabriela Păduraru, Laura-Iulia Bozomitu, Gabriela Ghiga, Monica Cristina Pânzaru, Lăcrămioara Ionela Butnariu, Ana Maria Scurtu, Elena Cojocaru, Vasile Valeriu Lupu, Laura-Mihaela Trandafir Journal of Clinical Medicine.2025; 14(24): 8798. CrossRef
The detrimental effect of autoimmune hepatitis in pregnancy: a systematic review and meta-analysis Hamza A. Khan, Mahnoor Khattak, Maaz B. Badshah, Nayab Sami, Subtain Hassan, Qaisar A. Khan, Sumaira Iram, Muhammad Mudasser, Farman Ullah, Dipta A. Biswas Annals of Medicine & Surgery.2025; 87(12): 8715. CrossRef
Association between ABO blood group system and autoimmune liver disease Yi Hong, Shijie Mu, Lin Wang Frontiers in Medicine.2025;[Epub] CrossRef
Associação entre hepatite autoimune e lúpus eritematoso sistêmico: Relato de caso Mariana de Andrade Nogueira, Carolina Yume Arazawa Research, Society and Development.2025; 14(12): e182141250455. CrossRef
Hepatic expression of tumor necrosis factor-α and evaluation of MAPK-p38 and NFκB signaling pathways in autoimmune hepatitis Márcia Maria Medeiros de Ataides Bezerra, Isabela Cristina de Farias Andrade, Júlio Cesar Dias de Melo Silva, Ana Clara Santos Costa, Raldney Ricardo Costa da Silva, Luydson Richardison Silva Vasconcelos, Maria de Fátima Cavalcanti Toscano Barreto, Leila Cytokine.2024; 177: 156541. CrossRef
Trends of Costs and Admission Rates Among Patients Admitted With Autoimmune Hepatitis: Analysis of US Hospitals Using the NIS Database David U. Lee, Kimberly Schuster, Aneesh Bahadur, Sophie Schellhammer, Reid Ponder, Emma Mitchell-Sparke, Gregory H. Fan, Ki J. Lee, Harrison Chou, Zurabi Lominadze Journal of Clinical and Experimental Hepatology.2024; 14(1): 101279. CrossRef
A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepatitis Xin Wang, Hui Liu, Peng Wang, Yuqi Wang, Yunyun Yi, Xin Li European Journal of Gastroenterology & Hepatology.2024; 36(1): 113. CrossRef
Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels Yun Chen, Jiacheng Liu, Jian Wang, Weihua Wu, Huali Wang, Yilin Liu, Zhiyi Zhang, Shaoqiu Zhang, Yifan Pan, Yiguang Li, Weimao Ding, Li Zhu, Chuanwu Zhu, Jie Li, Yuanwang Qiu, Rui Huang, Chao Wu Journal of Translational Autoimmunity.2024; 8: 100220. CrossRef
MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitis Genglin Zhang, Sensen Wu, Guangtao Xia Annals of Hepatology.2024; 29(2): 101183. CrossRef
Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease Feipeng Xu, Hua Zhang, Jiamei Chen, Junyi Zhan, Ping Liu, Wei Liu, Shenglan Qi, Yongping Mu Journal of Ethnopharmacology.2024; 321: 117514. CrossRef
STING modulates iron metabolism to promote liver injury and inflammation in acute immune hepatitis Jiamin Zhao, Zhiyong Yi, Guanghui Deng, Yunjia Li, Junjie Li, Mengchen Qin, Chaofeng Wu, Piao Luo, Shuoyi Ma, Lei Gao Free Radical Biology and Medicine.2024; 210: 367. CrossRef
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center Seyed Erfan Mehdi Nejad, Mohammad Heiat, Mohammad Javanbakht, Seyed Moayed Alavian, Mohammad Ali Abyazi Haris BMC Gastroenterology.2024;[Epub] CrossRef
Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope? Lujian Zhu, Qin Wang, Maodong Guo, Hao Fang, Ting Li, Yin Zhu, Huimian Jiang, Peiguang Xiao, Minli Hu Journal of Inflammation Research.2024; Volume 17: 171. CrossRef
Engineering M2 type macrophage-derived exosomes for autoimmune hepatitis immunotherapy via loading siRIPK3 Lu Zhang, Man Liu, Qiu Sun, Shuqin Cheng, Yirong Chi, Jie Zhang, Bangmao Wang, Lu Zhou, Jingwen Zhao Biomedicine & Pharmacotherapy.2024; 171: 116161. CrossRef
Development and validation of a noninvasive prediction model for significant hepatic liver fibrosis in Chinese patients with autoimmune hepatitis Hanzhu Chen, Wenya Ren, Xingdi Yang, Piao Hu, Shouhao Wang, Chengan Xu, Fei Lv, Yue Zhao, Qiaoqiao Yin, Wei Zheng, Jing Xu, Hongying Pan Annals of Hepatology.2024; 29(3): 101287. CrossRef
AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection Xiaohuan Lai, Haiyan Chen, Xiaofeng Dong, Guanlin Zhou, Dong Liang, Fei Xu, Hongxia Liu, Yingmin Luo, Hui Liu, Shaogui Wan European Journal of Gastroenterology & Hepatology.2024; 36(3): 338. CrossRef
Progress in Clinical Research on Belimumab in the Treatment of Rheumatic Diseases 保成 刘 Advances in Clinical Medicine.2024; 14(01): 1673. CrossRef
Retrospective, single-center analysis of autoimmune hepatitis in Jordanian children: clinical features, treatments, and outcomes Eyad Altamimi, Dana Al Omari, Hanadi Obeidat, Kamleh Barham BMC Pediatrics.2024;[Epub] CrossRef
Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data Sonali Kochhar, David N. Assis, Cara Mack, Hector S. Izurieta, Luigi Muratori, Alma Munoz, Dale Nordenberg, Jane F. Gidudu, Erin F. Blau, John M. Vierling Vaccine.2024; 42(7): 1812. CrossRef
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee Biomolecules.2024; 14(3): 277. CrossRef
Components from Curcuma longa (Turmeric) Against Hepatobiliary Diseases Based on Gut–Liver Axis: Pharmacotherapeutic Properties and Potential Clinical Applications Tianhui Gao, Shuyi Wang, Zongping Zhu, Liting Lin, Yirong Luo, Meigui Lu, Wan Liao The American Journal of Chinese Medicine.2024; 52(02): 387. CrossRef
Hepatitis autoinmune seronegativa: reporte de un caso Carlos Albeto Marín López, Nilson José Morales Córdoba, Félix Alejandro Bello Martínez, Maria Cecilia Loredo Mayorga Revista colombiana de Gastroenterología.2024; 39(1): 99. CrossRef
Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study A. O. Bueverov, S. V. Koblov, P. O. Bogomolov Russian Journal of Gastroenterology, Hepatology, Coloproctology.2024; 34(1): 31. CrossRef
Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Tsutomu Masaki BMC Gastroenterology.2024;[Epub] CrossRef
Autoimmune Liver Diseases and Rheumatoid Arthritis—Is There an Etiopathogenic Link? Ioana Ruxandra Mihai, Ciprian Rezus, Maria Alexandra Burlui, Anca Cardoneanu, Luana Andreea Macovei, Patricia Richter, Ioana Bratoiu, Elena Rezus International Journal of Molecular Sciences.2024; 25(7): 3848. CrossRef
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis Atsumasa Komori Clinical and Molecular Hepatology.2024; 30(2): 157. CrossRef
The etiology and differential diagnosis of “autoimmune hepatitis-like liver disease” in children: a single-center retrospective study Di Ma, Xinglou Liu, Guo Ai, Wen Pan, Lingling Liu, Yuan Huang, Yi Liao, Yuanyuan Lu, Zhan Zhang, Hua Zhou, Zhihua Huang, Xingjie Hao, Sainan Shu, Feng Fang Frontiers in Pediatrics.2024;[Epub] CrossRef
Autoimmune Hepatitis Management: Recent Advances and Future Prospects Rebeca Sierra, Ana Marenco-Flores, Marwan Alsaqa, Romelia Barba, Marcela Cuellar-Lobo, Carla Barberan, Leandro Sierra Livers.2024; 4(2): 240. CrossRef
Histopathology and its clinical correlation of liver biopsy in patients with treated autoimmune hepatitis Ujunwa Korie, Albina Joldoshova, Binny Khandakar, Xuchen Zhang, Yuanxin Liang Annals of Diagnostic Pathology.2024; 73: 152333. CrossRef
IAIH‐PG consensus for histological criteria of AIH: Multicentre validation with focus on chronic liver diseases in China Li Wang, Zhi‐Xiang Du, Hong‐Li Liu, Yu Zhang, Shuang‐Shuang Wang, Yi‐Fan Hu, Li‐Qiu Li, Ping Zhu, Yan‐Dan Zhong, Qing‐Fang Xiong, Yong‐Feng Yang Liver International.2024; 44(9): 2282. CrossRef
Otoimmün Hepatit Tanılı Erişkin Hastaların Değerlendirilmesi: Tek Merkez Deneyimi Aytül Coşar Ertem, Macit Gülten, Tuba Erürker Öztürk Uludağ Üniversitesi Tıp Fakültesi Dergisi.2024; 50(1): 23. CrossRef
Autoimmune hepatitis – an increasingly common cause of hypertransaminasaemia among children. Case report and literature review Hubert Paweł Szyller, Martyna Wrześniewska, Julia Wołoszczak, Joanna Braksator, Tomasz Pytrus Pediatria i Medycyna Rodzinna.2024; 20(2): 148. CrossRef
Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases Liuting Zeng, Kailin Yang, Ganpeng Yu, Wensa Hao, Xiaofei Zhu, Anqi Ge, Junpeng Chen, Lingyun Sun Cell Death & Disease.2024;[Epub] CrossRef
FKBP38 deletion exacerbates ConA-induced hepatitis by promoting the immune response through the MCP-1/p38 pathway Shuai Wang, Gengmiao Xiao, Minyi Tang, Xinyun Bi, Chaofeng Xing, Aolu Liu, Allan Z. Zhao, Fanghong Li International Immunopharmacology.2024; 138: 112659. CrossRef
Advanced MR imaging for detection of liver fibrosis and inflammation in autoimmune hepatitis: a state-of-the-art review Natália B.N. Gomes, Ulysses S. Torres, Maria Lucia C.G. Ferraz, Giuseppe D’Ippolito Seminars in Ultrasound, CT and MRI.2024;[Epub] CrossRef
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases Soon Kyu Lee, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee, Younghoon Kim, Ji Won Han, Hyun Yang, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Ke Diagnostics.2024; 14(16): 1745. CrossRef
Reply to correspondence on “Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity” Atsumasa Komori Clinical and Molecular Hepatology.2024; 30(4): 1035. CrossRef
The role of macrophage-derived exosomes in noncancer liver diseases: From intercellular crosstalk to clinical potential Xiaoli Fan, Jin Lin, Honglan Liu, Qiaoyu Deng, Yanyi Zheng, Xiaoze Wang, Li Yang International Immunopharmacology.2024; 143: 113437. CrossRef
Genus Paeonia polysaccharides: A review on their extractions, purifications, structural characteristics, biological activities, structure-activity relationships and applications Wenjing Hu, Aiqi Yu, Zhibin Wang, Yonghai Meng, Haixue Kuang, Meng Wang International Journal of Biological Macromolecules.2024; 282: 137089. CrossRef
Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora Jiawen Wu, Sixue Lyu, Di Guo, Na Yang, Yang Liu Frontiers in Immunology.2024;[Epub] CrossRef
Characteristics of the hepatotropic activity of cell-free cryopreserved biological agents in the model of autoimmune hepatitis F.V. Hladkykh, Т.І. Liadova The Journal of V. N. Karazin Kharkiv National University, Series "Medicine".2024; (50): 275. CrossRef
FEATURES OF THE CELL CYCLE OF HEPATOCYTES IN EXPERIMENTAL AUTOIMMUNE HEPATITIS ON THE BACKGROUND OF THE USE OF PLACENTA AND SPLEEN CRYOEXTRACTS, AS WELL AS THE CONDITIONED ENVIRONMENT OF MESENCHIMAL STEM CELLS Fedir V. Hladkykh, Tetiana I. Liadova, Serhii O. Soloviov Clinical and Preventive Medicine.2024; (7): 24. CrossRef
Ferroptosis and liver diseases Xin LI, Liang TAO, Meijuan ZHONG, Qian WU, Junjia MIN, Fudi WANG Journal of Zhejiang University (Medical Sciences).2024; 53(6): 747. CrossRef
CHARACTERISTICS OF PIGMENT METABOLISM FOLLOWING THE ADMINISTRATION OF ACELLULAR CRYOPRESERVED BIOLOGICAL AGENTS IN A MODEL OF AUTOIMMUNE HEPATITIS F.V. Hladkykh Biolohichni systemy.2024;[Epub] CrossRef
Case 9: A 62-Year-Old Woman With Jaundice and General Weakness Hee Sun Cho, Ji Won Han, Ji Hoon Kim, Heechul Nam, Pil Soo Sung, Si Hyun Bae Journal of Korean Medical Science.2023;[Epub] CrossRef
Therapeutic interventions of acute and chronic liver disorders: A comprehensive review Fares EM Ali, Mostafa K Abd El-Aziz, Elham I Sharab, Adel G Bakr World Journal of Hepatology.2023; 15(1): 19. CrossRef
Epidemiology and updated management for autoimmune liver disease Nae-Yun Heo, Haeryoung Kim Clinical and Molecular Hepatology.2023; 29(1): 194. CrossRef
Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience Tarek A. Tamimi, Malik Sallam, Deema Rayyan, Randa Farah, Dana Alkhulaifat, Abdallah Al-Ani, Reem Elmusa, Said Sharawi, Omar Tanash, Yaser Rayyan Journal of Clinical Medicine.2023; 12(2): 629. CrossRef
FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3 Huimian Jiang, Yan Fang, Yuxin Wang, Ting Li, Hongwei Lin, Jing Lin, Tongtong Pan, Qingxiu Liu, Jiaojian Lv, Dazhi Chen, Yongping Chen International Immunopharmacology.2023; 116: 109762. CrossRef
The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review Hunain Aslam, Fouzia Oza, Khalid Ahmed, Jonathan Kopel, Mark M. Aloysius, Aman Ali, Dushyant Singh Dahiya, Muhammad Aziz, Abhilash Perisetti, Hemant Goyal International Journal of Molecular Sciences.2023; 24(4): 3487. CrossRef
Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming Hao Chen, Lan-Lan Li, Yan Du Frontiers in Pharmacology.2023;[Epub] CrossRef
Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience Pierluigi Toniutto, Michela Zorzi, Lorenzo D’Alì, Annarosa Cussigh, Sara Cmet, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, Carla Di Loreto, Edmondo Falleti Journal of Clinical Medicine.2023; 12(8): 3008. CrossRef
Chemical constituents and hepatoprotective properties of Rhododendron simsii Planch extract in Con A-induced autoimmune hepatitis Fuqian Wang, Weiguang Sun, Zhou Lan, Yuan Zhou, Lulu Li, Ziheng Li, Ling Cheng, Qiuyun You, Qunfeng Yao Arabian Journal of Chemistry.2023; 16(8): 104955. CrossRef
An easy-to-use AIHF-nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis Zhiyi Zhang, Jian Wang, Huali Wang, Yuanwang Qiu, Li Zhu, Jiacheng Liu, Yun Chen, Yiguang Li, Yilin Liu, Yuxin Chen, Shengxia Yin, Xin Tong, Xiaomin Yan, Yali Xiong, Yongfeng Yang, Qun Zhang, Jie Li, Chuanwu Zhu, Chao Wu, Rui Huang Frontiers in Immunology.2023;[Epub] CrossRef
Clinical significance of serum antinuclear antibodies in patients with autoimmune hepatitis and comorbidity Hui Liu, Yuqi Wang, Peng Wang, Xin Wang, Yunyun Yi, Xin Li Clinical and Experimental Medicine.2023; 23(7): 3453. CrossRef
Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review Hao Zhou, Qing Ye Diseases.2023; 11(2): 80. CrossRef
Application of autoantibody detection in chronic liver disease Jinyu Han, Jin Chen, Yajie Wang iLABMED.2023; 1(2): 103. CrossRef
Role of Artesunate in Autoimmune Diseases and Signaling Pathways Jingsai Gu, Yishuang Xu, Dihao Hua, Zhen Chen Immunotherapy.2023; 15(14): 1183. CrossRef
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications Leonard Kaps, María José Limeres, Paul Schneider, Malin Svensson, Yanira Zeyn, Silvia Fraude, Maximiliano L. Cacicedo, Peter R. Galle, Stephan Gehring, Matthias Bros International Journal of Molecular Sciences.2023; 24(14): 11869. CrossRef
Research progress on the application of single-cell sequencing in autoimmune diseases Xueli Yang, Xianliang Hou, Junning Zhang, Zhenyu Liu, Guangyu Wang Genes & Immunity.2023; 24(5): 220. CrossRef
Advances in Understanding and Managing Autoimmune Hepatitis: A Narrative Review Vikas Yadav, Rabbia Irfan, Shamayel Safdar, Vyshnavidevi Sunkara, Chukwuyem Ekhator, Praful R Pendyala, Monika Devi, S M Iram Shahzed, Archana Das, Maryam Affaf, Sophia B Bellegarde, Riya Shrestha, Muhammad Arsal Naseem, Ahmed Al Khalifa Cureus.2023;[Epub] CrossRef
A case of combined chronic hepatitis C and autoimmune hepatitis with schistosomal liver disease Wenmei Sun, Peilin Xiao, Chanyan Wei, Jiaping Wang Asian Journal of Surgery.2023; 46(12): 6010. CrossRef
Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study Yugang Fu, Jiacheng Li, Yingying Zhu, Chong Chen, Jing Liu, Simin Gu, Yiyuan Zheng, Yong Li BMC Medical Genomics.2023;[Epub] CrossRef
A Novel Presentation of Autoimmune Hepatitis with IgG1 Elevation Yujiao Zhang, Bilal Niazi, Auda Auda, Angel Ann Chacko, Amer Jarri, Abdifatah Mohamed, Saad Ali, Hongfa Zhu, Syed Sirajuddin Case Reports in Gastroenterology.2023; 17(1): 281. CrossRef
TPN10475 alleviates concanavalin A-induced autoimmune hepatitis by limiting T cell development and function through inhibition of PI3K-AKT pathway Chun Wang, Mengyao Han, Xinhang Li, Jie Lv, Wei Zhuang, Ling Xie, Guangyu Liu, Kaidireya Saimaier, Sanxing Han, Changjie Shi, Qiuhong Hua, Ru Zhang, Xiangrui Jiang, Guiying Wang, Changsheng Du International Immunopharmacology.2023; 125: 111110. CrossRef
Detection of Lymphadenopathy as a Precursor to Autoimmune Liver Diseases Before Clinical Hepatitis Became Apparent: A Report of Two Cases Hiroshi Okano, Hiroki Tanaka, Shimpei Matsusaki, Katsumi Mukai, Akira Nishimura, Kana Asakawa, Youichirou Baba, Tetsuya Murata Cureus.2023;[Epub] CrossRef
Atorvastatin-Induced Autoimmune Hepatitis: A Case Report Jonathan Tse, Sam Natla, Rohit Mekala, Ian Crumm, Melissa H Olken Cureus.2023;[Epub] CrossRef
Acute iucterine hepatitis as a manifestation of severe autoimmune hepatitis Nikolai I. Kuznetsov, Valery V. Vasiliev, Elena S. Romanova, Galina Yu. Startseva, Ivan P. Fedunyak, Vladimir B. Musatov, Alexander М. Alekseev Russian Family Doctor.2023; 27(3): 55. CrossRef
Nutraceutical Properties of Syringic Acid in Civilization Diseases—Review Iga Bartel, Izabela Mandryk, Jarosław O. Horbańczuk, Agnieszka Wierzbicka, Magdalena Koszarska Nutrients.2023; 16(1): 10. CrossRef
Case of Autoimmune Hepatitis Romman Fatima, Afra Fatima, Viquasuddin Mohammed, Syed Ilyaz Euroasian journal of hepato-gastroenterology.2023; 13(2): 166. CrossRef
Value of Liver Function Tests in Cirrhosis Praveen Sharma Journal of Clinical and Experimental Hepatology.2022; 12(3): 948. CrossRef
Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis Bingtian Dong, Yuping Chen, Guorong Lyu, Xiaocen Yang Frontiers in Immunology.2022;[Epub] CrossRef
Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation Qiang Yu, Honghu Tu, Xueyi Yin, Chang Peng, Chuanyun Dou, Wenhua Yang, Wenbiao Wu, Xiaotong Guan, Jia Li, Hexin Yan, Yi Zang, Haowen Jiang, Qiang Xia Frontiers in Immunology.2022;[Epub] CrossRef
AhR Activation Leads to Attenuation of Murine Autoimmune Hepatitis: Single-Cell RNA-Seq Analysis Reveals Unique Immune Cell Phenotypes and Gene Expression Changes in the Liver Alkeiver S. Cannon, Bryan Latrell Holloman, Kiesha Wilson, Kathryn Miranda, Nicholas Dopkins, Prakash Nagarkatti, Mitzi Nagarkatti Frontiers in Immunology.2022;[Epub] CrossRef
Autoimmune Hepatitis—Challenging Diagnosis Aleksandra Mroskowiak, Agata Suleja, Maria Stec, Wiktoria Kuczmik, Maciej Migacz, Michał Holecki Medicina.2022; 58(7): 896. CrossRef
Polyguanine alleviated autoimmune hepatitis through regulation of macrophage receptor with collagenous structure and TLR4‐TRIF‐NF‐κB signalling Tingchen Cai, Lanman Xu, Dingchao Xia, Lujian Zhu, Yanhan Lin, Sijie Yu, Kailu Zhu, Xiaodong Wang, Chenwei Pan, Yongping Chen, Dazhi Chen Journal of Cellular and Molecular Medicine.2022; 26(22): 5690. CrossRef
Recent advances on drug delivery nanoplatforms for the treatment of autoimmune inflammatory diseases Jing Zhu, Weihong Chen, Yuansong Sun, Xiaoyi Huang, Ruixi Chu, Rui Wang, Deqing Zhou, Sheng Ye Materials Advances.2022; 3(21): 7687. CrossRef
Hepatocellular Carcinoma in Patients With Liver Cirrhosis Secondary to Autoimmune Hepatitis: A Case Series and Literature Review Hassan Perera Mesa, Lisbetty Lugo, Ellery Altshuler Cureus.2022;[Epub] CrossRef
Cirrhosis of the Liver: A Case Report and Literature Review of a Rare Case Presentation of Autoimmune Hepatitis With Systemic Sclerosis Shashank Banait, Chetan Burriwar, Jyoti Jain , Priti G Verma, Tanvi Banait, Madhura Joshi Cureus.2022;[Epub] CrossRef
Comprehensive immune cell analysis of human menstrual-blood-derived stem cells therapy to concanavalin A hepatitis Fen Zhang, Linxiao Fan, Qiuhong Liu, Shima Tang, Sainan Zhang, Lanlan Xiao, Lingjian Zhang, Qian Li, Nueraili Maihemuti, Lanjuan Li Frontiers in Immunology.2022;[Epub] CrossRef
The Translational Bridge between Inflammation and Hepatocarcinogenesis Sabine Gufler, Rita Seeboeck, Christoph Schatz, Johannes Haybaeck Cells.2022; 11(3): 533. CrossRef
Impact of hepatic steatosis on treatment response of autoimmune hepatitis: A retrospective multicentre analysis Peiyan Liu, Mingkai Li, Lili Zhao, Hongsheng Yu, Chang Zhao, Jianning Chen, Ruifang Shi, Li Zhou, Qi Zhou, Bin Wu, Jia Li Frontiers in Immunology.2022;[Epub] CrossRef
Autoimmune Hashimoto thyroiditis with concomitant autoimmune hepatitis Nevena Manevska, Natasa Stojkovska, Ljubica Tasheva, Marija Jovanovski-Srceva, Tanja Makazlieva, Sinisha Stojanoski Archives of Public Health.2022;[Epub] CrossRef
Hepatic Involvement of Diffuse Large B-Cell Lymphoma Mimicking Antinuclear Antibody-Negative Autoimmune Hepatitis Diagnosed by Liver Biopsy Euna Lee, Min-Kyu Kang, Gabin Moon, Mi-Jin Gu Medicina.2022; 59(1): 77. CrossRef
PATIENT WITH LIVER DISORDERS: EXPLORATION TOOLS AND TREATMENT Donea LORENZA, Camelia Salloum COJOCARIU, Ana-Maria SINGEAP, Irina GIRLEANU, Anca TRIFAN Annals of the Academy of Romanian Scientists Series on Biological Sciences.2022; 11(2): 112. CrossRef
The major diagnostic role of autoantibodies in the diagnosis of autoimmune hepatitis, a disease of all ages Linda Beenet Clinical and Molecular Hepatology.2021; 27(3): 510. CrossRef
Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis Weronika Domerecka, Anna Kowalska-Kępczyńska, Agata Michalak, Iwona Homa-Mlak, Radosław Mlak, Halina Cichoż-Lach, Teresa Małecka-Massalska Diagnostics.2021; 11(8): 1418. CrossRef
Pathogenesis of autoimmune hepatitis Jun-Hua Fan, Geng-Feng Liu, Xiao-Dan Lv, Rui-Zhi Zeng, Ling-Ling Zhan, Xiao-Ping Lv World Journal of Hepatology.2021; 13(8): 879. CrossRef
First
Prev
